These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31509481)

  • 21. The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
    Herden J; Ansmann L; Ernstmann N; Schnell D; Weißbac L
    Dtsch Arztebl Int; 2016 May; 113(19):329-36. PubMed ID: 27232362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
    Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC
    J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
    Modi PK; Kaufman SR; Borza T; Yan P; Miller DC; Skolarus TA; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
    Cancer; 2018 Aug; 124(16):3364-3371. PubMed ID: 29905943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
    Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
    Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.
    Radhakrishnan A; Grande D; Mitra N; Bekelman J; Stillson C; Pollack CE
    Cancer; 2017 May; 123(6):1027-1034. PubMed ID: 28263389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
    Schmidt B; Eapen RS; Cowan JE; Broering JM; Greene KL; Carroll PR; Cooperberg MR
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):117-124. PubMed ID: 30171230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
    Mahal AR; Butler S; Franco I; Muralidhar V; Larios D; Pike LRG; Zhao SG; Sanford NN; Dess RT; Feng FY; D'Amico AV; Spratt DE; Yu JB; Nguyen PL; Rebbeck TR; Mahal BA
    Cancer; 2019 Oct; 125(19):3338-3346. PubMed ID: 31251398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    Gaylis F; Cohen E; Calabrese R; Prime H; Dato P; Kane CJ
    Urology; 2016 Jul; 93():60-7. PubMed ID: 26876460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
    Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
    J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.
    Al Hussein Al Awamlh B; Ma X; Scherr D; Hu JC; Shoag JE
    Urology; 2020 Mar; 137():60-65. PubMed ID: 31948677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescent testicular microlithiasis: A case-based, multinational survey of clinical management practices.
    Brodie KE; Saltzman AF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):151.e1-151.e8. PubMed ID: 29428360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ; Fowler FJ; Bin L; Oesterling JE
    J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
    Kishan AU; Duchesne G; Wang PC; Rwigema JM; Saigal C; Rettig M; Steinberg ML; King CR
    Am J Clin Oncol; 2018 Jun; 41(6):549-557. PubMed ID: 27560157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.
    Gee WF; Holtgrewe HL; Blute ML; Miles BJ; Naslund MJ; Nellans RE; O'Leary MP; Thomas R; Painter MR; Meyer JJ; Rohner TJ; Cooper TP; Blizzard R; Fenninger RB; Emmons L
    J Urol; 1998 Nov; 160(5):1804-7. PubMed ID: 9783961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.
    Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
    Cancer; 2016 Oct; 122(20):3199-3206. PubMed ID: 27379732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction.
    O'Leary MP; Baum NH; Blizzard R; Blute ML; Cooper TP; Dineen MK; Fenninger RB; Gee WF; Gormley EA; Ignatoff JM; Nachtsheim DA; Painter MR; Thomas R; Wei JT;
    J Urol; 2002 Aug; 168(2):649-52. PubMed ID: 12131336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysis.
    Brandes A; Koerber F; Schwarzkopf L; Hunger M; Rogowski WH; Waidelich R
    BMC Health Serv Res; 2016 Nov; 16(1):664. PubMed ID: 27863486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer.
    Shahinian VB; Kuo YF
    BMC Urol; 2015 Apr; 15():25. PubMed ID: 25885745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.